<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2023-8.4.15</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-4345</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTURES</subject></subj-group></article-categories><title-group><article-title>Актуальные представления о болезни Пейрони (клиническая лекция)</article-title><trans-title-group xml:lang="en"><trans-title>Current concepts of Peyronie’s disease (clinical lecture)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9278-9739</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лелявин</surname><given-names>К. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Lelyavin</surname><given-names>K. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лелявин Кирилл Борисович – доктор медицинских наук, доцент кафедры скорой медицинской помощи и медицины катастроф </p><p>664049, г. Иркутск, Юбилейный, 100</p></bio><bio xml:lang="en"><p>Kirill B. Lelyavin – Dr. Sc. (Med.), Associate Professor at the Department of Emergency Medical Care and Disaster Medicine </p><p>Yubileyniy 100, Irkutsk 664049</p></bio><email xlink:type="simple">LelyavinK@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Иркутская государственная медицинская академия последипломного образования – филиал ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution></aff><aff xml:lang="en"><institution>Irkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Russian Medical Academy of Continuing Professional Education</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>03</day><month>10</month><year>2023</year></pub-date><volume>8</volume><issue>4</issue><fpage>136</fpage><lpage>146</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лелявин К.Б., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Лелявин К.Б.</copyright-holder><copyright-holder xml:lang="en">Lelyavin K.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/4345">https://www.actabiomedica.ru/jour/article/view/4345</self-uri><abstract><p>Статья представлена в формате лекционного материала. Болезнь Пейрони (фибропластическая индурация полового члена) представляет собой прогрессирующее фиброзное заболевание белочной оболочки полового члена, которое приводит к образованию фиброзных бляшек и может приводить к  пенильной деформации. В лекции с современных позиций рассмотрены вопросы этиологии, патогенеза, клиники и диагностики болезни Пейрони (БП). БП часто сочетается с болью в половом члене, эректильной дисфункцией и  вторичным тревожно-депрессивным состоянием. Несмотря на то, что эта проблема сохраняется не одно столетие, на сегодняшний день в  литературе нет единой концепции патогенеза. Растущий объём исследований показывает, что БП представляет собой хроническое нарушение локального процесса заживления ран в белочной оболочке и пространстве Смита. За последние 40 лет многочисленные доказательства указывают на  генетический фактор, предрасполагающий некоторых мужчин к развитию БП. Лечение мужчин с БП остаётся сложной проблемой, стоящей перед клиницистами, работающими в области урологии. Методы лечения БП разнообразны и включают пероральную, местную, внутриочаговую и  тракционную терапию, оперативное лечение. Действующие стандарты клинической помощи при БП направлены на устранение симптомов, поскольку в настоящее время не разработаны методы лечения, направленные на  ликвидацию причин, вызывающих  её и способствующих прогрессированию заболевания. Коллагеназа Clostridium histolyticum показала свою эффективность в лечении БП, но её эффективность и безопасность остаются спорными. Хирургия остаётся наиболее эффективным методом лечения БП и считается золотым стандартом. Выбор хирургической техники зависит от длины полового члена, степени деформации, эректильной функции, ожиданий пациентов и предпочтений хирурга. Для закрытия дефекта белочной оболочки после частичного иссечения или разреза бляшки можно использовать различные хирургические методики и трансплантационные материалы (аутологичные и неаутологичные).</p></abstract><trans-abstract xml:lang="en"><p>The article is presented in the format of a lecture. Peyronie’s disease (induratio penis plastica) is a progressive fibrotic disorder of the penile tunica albuginea that results in fibrotic penile plaques and  can cause penile deformity. The issues of  etiology, pathogenesis, clinical picture and diagnosis of Peyronie’s disease (PD) are reviewed in the lecture from the modern points of view. PD is frequently associated with penile pain, erectile dysfunction, and a secondary anxiety-depressive state. Despite the existence of this problem for several centuries, no unified concept of the Peyronie’s disease pathogenesis can be found in literature. A growing amount of research has shown that PD is a chronical disorder of local wound healing process within the tunica albuginea and the Smith’s space. Over the past 40 years, multiple lines of evidence have pointed to a genetic factor that predisposes some men to the development of Peyronie’s disease. Treating men with PD remains a challenging problem for clinicians working in urology. Given the high prevalence of PD and its significant impact on affected men, its better understanding is essential. Treatment methods for PD are varied and include oral, local, intralesional and traction therapy, and surgical treatment. Current clinical care standards for PD are aimed at the symptom suppression, as there are currently no treatment for PD that can eliminate its causes or progression. Clostridium histolyticum collagenase has shown its effectiveness in  treating PD, but its efficacy and safety remain controversial. Surgery remains the most effective method for PD treatment and is considered to be “gold standard”. The choice of the  surgical technique depends on the length of the penis, degree of deformity, erectile function, patients’ expectations and surgeon’s preferences. Various surgical techniques and grafting materials (autologous and non-autologous) can  be used for  the coverage of  the tunica albuginea defect after partial plaque excision or incision. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>фибропластическая индурация полового члена</kwd><kwd>болезнь Пейрони</kwd><kwd>искривление полового члена</kwd><kwd>эректильная дисфункция</kwd><kwd>заместительная корпоропластика</kwd><kwd>буккальный трансплантат</kwd></kwd-group><kwd-group xml:lang="en"><kwd>fibroplastic penile induration</kwd><kwd>Peyronie’s disease</kwd><kwd>curvature of the penis</kwd><kwd>erectile dysfunction</kwd><kwd>substitutive corporoplasty</kwd><kwd>buccal graft</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Малей М. Франсуа Пейрони – лейб-медик короля, заложивший фундамент будущего урологии. Медицинские аспекты здоровья мужчин. 2014; 4(15): 61-63.</mixed-citation><mixed-citation xml:lang="en">Maley M. François Peyronie – a surgeon in ordinary to the King who laid the foundation for the future of urology. Medical Aspects of Man’s Health. 2014; 4(15): 61-63. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez JA, Jarow JP. Penile vascular evaluation of men with Peyronie’s disease. J Urol. 1993; 149: 53-55. doi: 10.1016/s0022-5347(17)35997-9</mixed-citation><mixed-citation xml:lang="en">Lopez JA, Jarow JP. Penile vascular evaluation of men with Peyronie’s disease. J Urol. 1993; 149: 53-55. doi: 10.1016/s0022-5347(17)35997-9</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shenoy-Bhangle A, Perez-Johnston R, Singh A. Penile imaging. Radiol Clin North Am. 2012; 50(6): 1167-1181. doi: 10.1016/j.rcl.2012.08.009</mixed-citation><mixed-citation xml:lang="en">Shenoy-Bhangle A, Perez-Johnston R, Singh A. Penile imaging. Radiol Clin North Am. 2012; 50(6): 1167-1181. doi: 10.1016/j.rcl.2012.08.009</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT. The incidence of Peyronie’s disease in Rochester, Minnesota, 1950 through 1984. J Urol. 1991; 146(4): 1007-1009. doi: 10.1016/s0022-5347(17)37988-0</mixed-citation><mixed-citation xml:lang="en">Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT. The incidence of Peyronie’s disease in Rochester, Minnesota, 1950 through 1984. J Urol. 1991; 146(4): 1007-1009. doi: 10.1016/s0022-5347(17)37988-0</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Flores JM, Salter CA, Nascimento B, Terrier JE, Taniguchi H, Bernie HL, et al. The prevalence and predictors of penile pain in men with Peyronie’s disease. Sex Med. 2021; 9(4): 100398. doi: 10.1016/j.esxm.2021.100398</mixed-citation><mixed-citation xml:lang="en">Flores JM, Salter CA, Nascimento B, Terrier JE, Taniguchi H, Bernie HL, et al. The prevalence and predictors of penile pain in men with Peyronie’s disease. Sex Med. 2021; 9(4): 100398. doi: 10.1016/j.esxm.2021.100398</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie’s disease: Results of a large survey. BJU Int. 2001; 88(7): 727-730. doi: 10.1046/j.1464-4096.2001.02436.x</mixed-citation><mixed-citation xml:lang="en">Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie’s disease: Results of a large survey. BJU Int. 2001; 88(7): 727-730. doi: 10.1046/j.1464-4096.2001.02436.x</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Manka MG, White LA, Yafi FA, Mulhall JP, Levine LA, Ziegelmann MJ. Comparing and contrasting Peyronie’s disease guidelines: Points of consensus and deviation. J Sex Med. 2021; 18(2): 363-375. doi: 10.1016/j.jsxm.2020.11.013</mixed-citation><mixed-citation xml:lang="en">Manka MG, White LA, Yafi FA, Mulhall JP, Levine LA, Ziegelmann MJ. Comparing and contrasting Peyronie’s disease guidelines: Points of consensus and deviation. J Sex Med. 2021; 18(2): 363-375. doi: 10.1016/j.jsxm.2020.11.013</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. A population-based study of Peyronie’s disease: Prevalence and treatment patterns in the United states. Adv Urol. 2011; 2011: 282503. doi: 10.1155/2011/282503</mixed-citation><mixed-citation xml:lang="en">Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. A population-based study of Peyronie’s disease: Prevalence and treatment patterns in the United states. Adv Urol. 2011; 2011: 282503. doi: 10.1155/2011/282503</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E, et al. Peyronie’s disease: Prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50–69 years. Eur Urol. 2001; 40(5): 525-530. doi: 10.1159/000049830</mixed-citation><mixed-citation xml:lang="en">La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E, et al. Peyronie’s disease: Prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50–69 years. Eur Urol. 2001; 40(5): 525-530. doi: 10.1159/000049830</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sommer F, Schwarzer U, Wassmer G, Bloch W, Braun M, Klotz T, et al. Epidemiology of Peyronie’s disease. Int J Impot Res. 2002; 14(5): 379-383. doi: 10.1038/sj.ijir.3900863</mixed-citation><mixed-citation xml:lang="en">Sommer F, Schwarzer U, Wassmer G, Bloch W, Braun M, Klotz T, et al. Epidemiology of Peyronie’s disease. Int J Impot Res. 2002; 14(5): 379-383. doi: 10.1038/sj.ijir.3900863</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Shiraishi K. The prevalence of Peyronie’s disease in Japan: A study in men undergoing maintenance hemodialysis and routine health checks. J Sex Med. 2012; 9(10): 2716-2723. doi: 10.1111/j.1743-6109.2012.02868.x</mixed-citation><mixed-citation xml:lang="en">Shiraishi K. The prevalence of Peyronie’s disease in Japan: A study in men undergoing maintenance hemodialysis and routine health checks. J Sex Med. 2012; 9(10): 2716-2723. doi: 10.1111/j.1743-6109.2012.02868.x</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kadioglu A, Dincer M, Salabas E, Culha MG, Akdere H, Cilesiz NC. A population-based study of Peyronie’s disease in Turkey: Prevalence and related comorbidities. Sex Med. 2020; 8(4): 679-685. doi: 10.1016/j.esxm.2020.09.002</mixed-citation><mixed-citation xml:lang="en">Kadioglu A, Dincer M, Salabas E, Culha MG, Akdere H, Cilesiz NC. A population-based study of Peyronie’s disease in Turkey: Prevalence and related comorbidities. Sex Med. 2020; 8(4): 679-685. doi: 10.1016/j.esxm.2020.09.002</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Щеплев П.А., Данилов И.А., Колотинский А.Б., Гвасалия Б.Р., Гарин Н.Н. Клинические рекомендации. Болезнь Пейрони. Андрология и генитальная хирургия. 2007; 8(1): 55-58.</mixed-citation><mixed-citation xml:lang="en">Shcheplev PA, Danilov IA, Kolotinsky AB, Gvasalia BR, Garin NN. Clinical guidelines. Peyronie’s disease. Andrology and Genital Surgery. 2007; 8(1): 55-58. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ostrowski KA, Gannon JR, Walsh TJ. A review of the epidemiology and treatment of Peyronie’s disease. Res Rep Urol. 2016; 8: 61-70. doi: 10.2147/RRU.S65620</mixed-citation><mixed-citation xml:lang="en">Ostrowski KA, Gannon JR, Walsh TJ. A review of the epidemiology and treatment of Peyronie’s disease. Res Rep Urol. 2016; 8: 61-70. doi: 10.2147/RRU.S65620</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Levine LA. Standard operating procedures for Peyronie’s disease. J Sex Med. 2013; 10(1): 230-244. doi: 10.1111/j.1743-6109.2012.03003.x</mixed-citation><mixed-citation xml:lang="en">Levine LA. Standard operating procedures for Peyronie’s disease. J Sex Med. 2013; 10(1): 230-244. doi: 10.1111/j.1743-6109.2012.03003.x</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson D, Laforge J, Ross MM, Vanlangendonck R, Hasoon J, Viswanath O, et al. Male sexual dysfunction. Health Psychol Res. 2022; 10(3): 37533. doi: 10.52965/001c.37533</mixed-citation><mixed-citation xml:lang="en">Anderson D, Laforge J, Ross MM, Vanlangendonck R, Hasoon J, Viswanath O, et al. Male sexual dysfunction. Health Psychol Res. 2022; 10(3): 37533. doi: 10.52965/001c.37533</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Tal R. Peyronie’s disease following radical prostatectomy: incidence and predictors. J Sex Med. 2010; 7(3): 1254-1261. doi: 10.1111/j.1743-6109.2012.03003.x</mixed-citation><mixed-citation xml:lang="en">Tal R. Peyronie’s disease following radical prostatectomy: incidence and predictors. J Sex Med. 2010; 7(3): 1254-1261. doi: 10.1111/j.1743-6109.2012.03003.x</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mulhall JP. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol. 2004; 171(6): 2350-2353. doi: 10.1097/01.ju.0000127744.18878.f1</mixed-citation><mixed-citation xml:lang="en">Mulhall JP. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol. 2004; 171(6): 2350-2353. doi: 10.1097/01.ju.0000127744.18878.f1</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Paulis G, De Giorgio G, Paulis L. Role of oxidative stress in Peyronie’s disease: Biochemical evidence and experiences of treatment with antioxidants. Int J Mol Sci. 2022; 23(24): 15969. doi: 10.3390/ijms232415969</mixed-citation><mixed-citation xml:lang="en">Paulis G, De Giorgio G, Paulis L. Role of oxidative stress in Peyronie’s disease: Biochemical evidence and experiences of treatment with antioxidants. Int J Mol Sci. 2022; 23(24): 15969. doi: 10.3390/ijms232415969</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">El-Sakka AI. Peyronie’s disease in diabetic patients being screened for erectile dysfunction. European Urol. 2006; 49: 564-569.</mixed-citation><mixed-citation xml:lang="en">El-Sakka AI. Peyronie’s disease in diabetic patients being screened for erectile dysfunction. European Urol. 2006; 49: 564-569.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lo EM, Hotaling JM, Pastuszak AW. Urologic conditions associated with malignancy. Urol Oncol. 2020; 38(1): 23-30. doi: 10.1016/j.urolonc.2018.12.018</mixed-citation><mixed-citation xml:lang="en">Lo EM, Hotaling JM, Pastuszak AW. Urologic conditions associated with malignancy. Urol Oncol. 2020; 38(1): 23-30. doi: 10.1016/j.urolonc.2018.12.018</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Pastuszak AW, Thirumavalavan N, Kohn TP, Lipshultz LI, Eisenberg ML. Increased risk of cancer in men with Peyronie’s disease: A cohort study using a large united states insurance claims database. Sex Med. 2019; 7(4): 403-408. doi: 10.1016/j.esxm.2019.08.007</mixed-citation><mixed-citation xml:lang="en">Pastuszak AW, Thirumavalavan N, Kohn TP, Lipshultz LI, Eisenberg ML. Increased risk of cancer in men with Peyronie’s disease: A cohort study using a large united states insurance claims database. Sex Med. 2019; 7(4): 403-408. doi: 10.1016/j.esxm.2019.08.007</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kirby EW, Verges D, Matthews J, Carson CC, Coward RM. Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie’s disease or erectile dysfunction and does not correlate with Peyronie’s disease severity. J Sex Med. 2015; 12(3): 690-696. doi: 10.1111/jsm.12805</mixed-citation><mixed-citation xml:lang="en">Kirby EW, Verges D, Matthews J, Carson CC, Coward RM. Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie’s disease or erectile dysfunction and does not correlate with Peyronie’s disease severity. J Sex Med. 2015; 12(3): 690-696. doi: 10.1111/jsm.12805</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mitsui Y, Kobayashi H, Yamabe F, Nakajima K, Nagao K. ABO blood type and risk of Peyronie’s disease in Japanese males. World J Mens Health. 2022; 40(3): 509-516. doi: 10.5534/wjmh.210126</mixed-citation><mixed-citation xml:lang="en">Mitsui Y, Kobayashi H, Yamabe F, Nakajima K, Nagao K. ABO blood type and risk of Peyronie’s disease in Japanese males. World J Mens Health. 2022; 40(3): 509-516. doi: 10.5534/wjmh.210126</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Babu A, Kayes O. Recent advances in managing Peyronie’s disease. F1000Res. 2020; 9: F1000 Faculty Rev-381. doi: 10.12688/f1000research.20557</mixed-citation><mixed-citation xml:lang="en">Babu A, Kayes O. Recent advances in managing Peyronie’s disease. F1000Res. 2020; 9: F1000 Faculty Rev-381. doi: 10.12688/f1000research.20557</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Krakhotkin DV, Chernylovskyi VA, Mottrie A, Greco F, Bugaev RA. New insights into the pathogenesis of Peyronie’s disease: A narrative review. Chronic Dis Transl Med. 2020; 6(3): 165-181. doi: 10.1016/j.cdtm.2020.06.001</mixed-citation><mixed-citation xml:lang="en">Krakhotkin DV, Chernylovskyi VA, Mottrie A, Greco F, Bugaev RA. New insights into the pathogenesis of Peyronie’s disease: A narrative review. Chronic Dis Transl Med. 2020; 6(3): 165-181. doi: 10.1016/j.cdtm.2020.06.001</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF. Peyronie’s disease is associated with an increase in transforming growth factor-beta protein expression. J Urol. 1997; 158: 1391-1394. doi: 10.1016/S0022-5347(01)64223-X</mixed-citation><mixed-citation xml:lang="en">El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF. Peyronie’s disease is associated with an increase in transforming growth factor-beta protein expression. J Urol. 1997; 158: 1391-1394. doi: 10.1016/S0022-5347(01)64223-X</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Devine CJ Jr. International conference on Peyronie’s disease advances in basic and clinical research. March 17–19, 1993. Introduction. J Urol. 1997; 157: 272-275.</mixed-citation><mixed-citation xml:lang="en">Devine CJ Jr. International conference on Peyronie’s disease advances in basic and clinical research. March 17–19, 1993. Introduction. J Urol. 1997; 157: 272-275.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez-Cadavid NF, Magee TR, Ferrini M, Qian A, Vernet D, Rajfer J. Gene expression in Peyronie’s disease. Int J Impo Res. 2002; 14: 361-374. doi: 10.1038/sj.ijir.3900873</mixed-citation><mixed-citation xml:lang="en">Gonzalez-Cadavid NF, Magee TR, Ferrini M, Qian A, Vernet D, Rajfer J. Gene expression in Peyronie’s disease. Int J Impo Res. 2002; 14: 361-374. doi: 10.1038/sj.ijir.3900873</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell J, Alzubaidi R. Understanding the cellular basis and pathophysiology of Peyronie’s disease to optimize treatment for erectile dysfunction. Transl Androl Urol. 2017; 6(1): 46-59. doi: 10.21037/tau.2016.11.01</mixed-citation><mixed-citation xml:lang="en">Campbell J, Alzubaidi R. Understanding the cellular basis and pathophysiology of Peyronie’s disease to optimize treatment for erectile dysfunction. Transl Androl Urol. 2017; 6(1): 46-59. doi: 10.21037/tau.2016.11.01</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Gabrielsen JS. Peyronie’s disease: Is it genetic or not? Transl Androl Urol. 2020; 9(2): 262-268. doi: 10.21037/tau.2019.10.21</mixed-citation><mixed-citation xml:lang="en">Gabrielsen JS. Peyronie’s disease: Is it genetic or not? Transl Androl Urol. 2020; 9(2): 262-268. doi: 10.21037/tau.2019.10.21</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Moreno SA, Morgentaler A. Testosterone deficiency and Peyronie’s disease: Pilot data suggesting a significant relationship. J Sex Med. 2009; 6(6): 1729-1735. doi: 10.1111/j.1743-6109.2009.01250.x</mixed-citation><mixed-citation xml:lang="en">Moreno SA, Morgentaler A. Testosterone deficiency and Peyronie’s disease: Pilot data suggesting a significant relationship. J Sex Med. 2009; 6(6): 1729-1735. doi: 10.1111/j.1743-6109.2009.01250.x</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Hatzimouratidis K, Giuliano F, Moncada I, Muneer A, Salonia A, Verze P. EAU guidelines on erectile dysfunction, premature ejaculation, penile curvature and priapism. Arnhem: European Association of Urology; 2018.</mixed-citation><mixed-citation xml:lang="en">Hatzimouratidis K, Giuliano F, Moncada I, Muneer A, Salonia A, Verze P. EAU guidelines on erectile dysfunction, premature ejaculation, penile curvature and priapism. Arnhem: European Association of Urology; 2018.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Moisés da Silva GV, Dávila FJ, Rosito TE, Martins FE. Global perspective on the management of Peyronie’s disease. Front Reprod. Health. 2022; 4: 863844. doi: 10.3389/frph.2022.863844</mixed-citation><mixed-citation xml:lang="en">Moisés da Silva GV, Dávila FJ, Rosito TE, Martins FE. Global perspective on the management of Peyronie’s disease. Front Reprod. Health. 2022; 4: 863844. doi: 10.3389/frph.2022.863844</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Мазо В.Е. Консервативное лечение фибропластической индурации полового члена болезни Пейрони. Урология и нефрология. 1984; 3: 35-37.</mixed-citation><mixed-citation xml:lang="en">Mazo VE. Conservative treatment of penile fibroplastic induration in Peyronie’s disease. Urologiia i nefrologiia. 1984; 3: 35-37. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Iacono F, Barra S, De Rosa G, Boscaino A, Lotti T. Microstructural disorders of tunica albuginea in patients affected by Peyronie’s disease with or without erection dysfunction. J Urol. 1993; 150(6): 1806-1809. doi: 10.1016/s0022-5347(17)35901-3</mixed-citation><mixed-citation xml:lang="en">Iacono F, Barra S, De Rosa G, Boscaino A, Lotti T. Microstructural disorders of tunica albuginea in patients affected by Peyronie’s disease with or without erection dysfunction. J Urol. 1993; 150(6): 1806-1809. doi: 10.1016/s0022-5347(17)35901-3</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Kelâmi A. Classification of congenital and acquired penile deviation. Urol Int. 1983; 38: 229-233. doi: 10.1159/000280897</mixed-citation><mixed-citation xml:lang="en">Kelâmi A. Classification of congenital and acquired penile deviation. Urol Int. 1983; 38: 229-233. doi: 10.1159/000280897</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Москалева Ю.С., Остапченко А.Ю., Корнеев И.А. Болезнь Пейрони. Урологические ведомости. 2015; 5(4): 30-35.</mixed-citation><mixed-citation xml:lang="en">Moskaleva YS, Ostapchenko AY, Korneyev IA. Peyronie’s disease. Urology Reports (St.-Petersburg). 2015; 5(4): 30-35. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Guidelines of European Association of Urology (EAU). 2021. URL: http://uroweb.org/guidelines/compilations-of-all-guidelines [date of access: 04.12.2022].</mixed-citation><mixed-citation xml:lang="en">Guidelines of European Association of Urology (EAU). 2021. URL: http://uroweb.org/guidelines/compilations-of-all-guidelines [date of access: 04.12.2022].</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Hsi RS, Hotaling JM, Hartzler AL, Holt SK, Walsh TJ. Validity and reliability of a smartphone application for the assessment of penile deformity in Peyronie’s disease. J Sex Med. 2013; 10(7): 1867-1873. doi: 10.1111/jsm.12136</mixed-citation><mixed-citation xml:lang="en">Hsi RS, Hotaling JM, Hartzler AL, Holt SK, Walsh TJ. Validity and reliability of a smartphone application for the assessment of penile deformity in Peyronie’s disease. J Sex Med. 2013; 10(7): 1867-1873. doi: 10.1111/jsm.12136</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y, Zheng D, Liu X, Shi X, Shu S, Li J. Ultrasound on erect penis improves plaque identification in patients with Peyronie’s disease. Front Pharmacol. 2019; 10: 312. doi: 10.3389/fphar.2019.00312</mixed-citation><mixed-citation xml:lang="en">Liu Y, Zheng D, Liu X, Shi X, Shu S, Li J. Ultrasound on erect penis improves plaque identification in patients with Peyronie’s disease. Front Pharmacol. 2019; 10: 312. doi: 10.3389/fphar.2019.00312</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Walsham WJ, Spencer WG. Sores on the penis. In: Spencer WG. Surgery: Its theory and practice; 8th ed. London: J. &amp; A. Curchill; 1903.</mixed-citation><mixed-citation xml:lang="en">Walsham WJ, Spencer WG. Sores on the penis. In: Spencer WG. Surgery: Its theory and practice; 8th ed. London: J. &amp; A. Curchill; 1903.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Chong W, Tan RB. Injectable therapy for Peyronie’s disease. Transl Androl Urol. 2016; 5(3): 310-317. doi: 10.21037/tau.2016.03.15</mixed-citation><mixed-citation xml:lang="en">Chong W, Tan RB. Injectable therapy for Peyronie’s disease. Transl Androl Urol. 2016; 5(3): 310-317. doi: 10.21037/tau.2016.03.15</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Wayne GF, Cordon BH. Contemporary surgical and nonsurgical management of Peyronie’s disease. Transl Androl Urol. 2018; 7(4): 603-617. doi: 10.21037/tau.2018.04.06</mixed-citation><mixed-citation xml:lang="en">Wayne GF, Cordon BH. Contemporary surgical and nonsurgical management of Peyronie’s disease. Transl Androl Urol. 2018; 7(4): 603-617. doi: 10.21037/tau.2018.04.06</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Osmonov D, Ragheb A, Ward S, Blecher G, Falcone M, Soave A, et al. ESSM position statement on surgical treatment of Peyronie’s disease. Sex Med. 2022; 10(1): 100459. doi: 10.1016/j.esxm.2021.100459</mixed-citation><mixed-citation xml:lang="en">Osmonov D, Ragheb A, Ward S, Blecher G, Falcone M, Soave A, et al. ESSM position statement on surgical treatment of Peyronie’s disease. Sex Med. 2022; 10(1): 100459. doi: 10.1016/j.esxm.2021.100459</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Павлов В.Н., Бакиров А.А., Казихинуров Р.А., Казихинуров А.А., Агавердиев М.А., Папоян А.О., и др. Корпоропластика при болезни Пейрони: обзор литературы. Креативная хирургия и онкология. 2021; 11(3): 209-219.</mixed-citation><mixed-citation xml:lang="en">Pavlov VN, Bakirov AA, Kazikhinurov RA, Kazikhinurov AA, Agaverdiev MA, Papoyan AO, et al. Corporoplasty in Peyronie’s disease: A literature review. Creative Surgery and Oncology. 2021; 11(3): 209-219. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Повелица Э.А., Дорошевич Р.В., Доста Н.И., Пархоменко О.В. Корпоропластика при болезни Пейрони с использованием ксенографта и синтетического графта. Андрология и генитальная хирургия. 2019; 20(2): 48-55.</mixed-citation><mixed-citation xml:lang="en">Povelitsa ВA, Darashevich RV, Dosta NI, Parhomenko OV The corporoplasty of Peyronie’s disease with the xenograft and the synthetic graft. Andrology and Genital Surgery. 2019; 20(2): 48-55. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Котов С.В., Юсуфов А.Г., Семенов М.К. Трансплантат слизистой щеки – концепция «идеального графта» в хирургическом лечении болезни Пейрони. Урология. 2017; 7(4): 68-72.</mixed-citation><mixed-citation xml:lang="en">Kotov SV, Yusufov AG, Semenov MK. Buccal mucosa transplant – the concept of «ideal graft» in surgical management of Peyronie’s disease. Urologiia. 2017; 7(4): 68-72. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Ахвледиани Н.Д., Пушкарь Д.Ю., Берников А.Н., Чернушенко А.С., Рева И.А. Фаллопротезирование через завенечный доступ с безграфтинговой корпоропластикой при эректильной дисфункции, сочетанной с болезнью Пейрони. Урология. 2019; 3: 124-127.</mixed-citation><mixed-citation xml:lang="en">Akhvlediani ND, Pushkar DYu, Bernikov AN, Chernushenko AS, Reva IA. Penile prosthesis implantation through subcoronal approach with graft-free corporoplasty in patients with Peyronie disease with concomitant erectile dysfunction. Urologiia. 2019; 3: 124-127. (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
